Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents

Current treatment with EES is associated with a lower risk of very late stent thrombosis compared with early-generation drug-eluting stents.